Polyrizon Submits FDA Pre-Sub Package for Allergy Blocker
Ticker: PLRZ · Form: 6-K · Filed: Sep 19, 2025 · CIK: 1893645
| Field | Detail |
|---|---|
| Company | Polyrizon Ltd. (PLRZ) |
| Form Type | 6-K |
| Filed Date | Sep 19, 2025 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | bullish |
Sentiment: bullish
Topics: FDA submission, medical device, regulatory filing
TL;DR
Polyrizon just filed its PL-14 Allergy Blocker with the FDA, big step for allergy treatment!
AI Summary
Polyrizon Ltd. announced on September 19, 2025, that it has submitted a pre-submission package to the U.S. Food and Drug Administration (FDA) for its PL-14 Allergy Blocker. This submission is a significant step towards seeking FDA approval for the novel medical device.
Why It Matters
This FDA submission is a critical milestone for Polyrizon, potentially paving the way for the commercialization of their PL-14 Allergy Blocker and offering a new treatment option for allergy sufferers.
Risk Assessment
Risk Level: medium — FDA submissions are complex and success is not guaranteed, carrying inherent regulatory and market adoption risks.
Key Players & Entities
- Polyrizon Ltd. (company) — Registrant
- PL-14 Allergy Blocker (product) — Medical device for allergy treatment
- U.S. Food and Drug Administration (FDA) (company) — Regulatory body
- September 19, 2025 (date) — Date of press release and submission
FAQ
What is the purpose of the pre-submission package submitted to the FDA?
The pre-submission package is submitted to the FDA to obtain feedback on the company's development and regulatory pathway for the PL-14 Allergy Blocker before a formal submission for marketing approval.
What is the product Polyrizon is seeking approval for?
Polyrizon is seeking approval for its PL-14 Allergy Blocker, a novel medical device.
When was the press release regarding the FDA submission issued?
The press release was issued on September 19, 2025.
What form is Polyrizon Ltd. filing with the SEC?
Polyrizon Ltd. is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What are the SEC file numbers for the Form S-8 registration statements mentioned?
The SEC file numbers for the Form S-8 registration statements are 333-284410 and 333-288923.
Filing Stats: 258 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2025-09-19 08:39:02
Filing Documents
- ea0258036-6k_polyrizon.htm (6-K) — 10KB
- ea025803601ex99-1_polyrizon.htm (EX-99.1) — 9KB
- 0001213900-25-089242.txt ( ) — 20KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Polyrizon Ltd. Date: September 19, 2025 By: /s/ Tomer Izraeli Name: Tomer Izraeli Title: Chief Executive Officer 2